E
Eugene R. Hickey
Researcher at Boehringer Ingelheim
Publications - 56
Citations - 3867
Eugene R. Hickey is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Cathepsin & Cannabinoid receptor type 2. The author has an hindex of 23, co-authored 56 publications receiving 3668 citations.
Papers
More filters
Journal ArticleDOI
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.
Christopher Pargellis,Liang Tong,Liang Tong,L. Churchill,Pier F. Cirillo,Gilmore Thomas A,A. G. Graham,Peter M. Grob,Eugene R. Hickey,Neil Moss,Susan Pav,John R. Regan +11 more
TL;DR: A new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase is reported, requiring a large conformational change not observed previously for any of the protein Ser/Thr kinases.
Journal ArticleDOI
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.
Stefan Kubicek,Roderick J. O'Sullivan,E. Michael August,Eugene R. Hickey,Qiang Zhang,Miguel L L. Teodoro,Stephen Rea,Karl Mechtler,Jennifer A. Kowalski,Carol Ann Homon,Terence A. Kelly,Thomas Jenuwein +11 more
TL;DR: In this article, the authors identify a biologically active HMTase inhibitor that allows for the transient modulation of H3K9me2 marks in mammalian chromatin and demonstrate that transient incubation of several cell lines with BIX-01294 lowers bulk H3 K 9me2 levels that are restored upon removal of the inhibitor.
Journal ArticleDOI
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.
John R. Regan,Steffen Breitfelder,Pier F. Cirillo,Gilmore Thomas A,A. G. Graham,Eugene R. Hickey,Bernhard Klaus,Jeffrey B. Madwed,Moriak Monica Helen,Neil Moss,Chris Pargellis,Sue Pav,Alfred Proto,Alan David Swinamer,Liang Tong,Carol A. Torcellini +15 more
TL;DR: A key binding domain that is distinct from the adenosine 5'-triphoshate (ATP) binding site is exposed when the conserved activation loop adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.
Journal ArticleDOI
Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase
Kevin Chungeng Qian,Lian Wang,Eugene R. Hickey,Joey Studts,Kevin Barringer,Charline Peng,Anthony Kronkaitis,Jun Li,Andre White,Sheenah Mische,Bennett T. Farmer +10 more
TL;DR: Analysis of the reported Pim-1 kinase-domain structures leads to a hypothesis as to how Pim kinase activity might be regulated in vivo.
Patent
Aromatic heterocyclic compounds as anti-inflammatory agents
TL;DR: In this article, novel aromatic heterocyclic compounds of formula (I) wherein Ar1,Ar2,L,Q and X are described are described. And processes of making such compounds are also disclosed.